483 Document: K.C. Pharmaceuticals, Inc, Feb 13, 2023

FDANews 483 K.C. Pharmaceuticals, Inc Feb 13 2023 top
Christopher R. Czajka FDA Investigator Amir Alavi FDA Investigator

On Feb 13, 2023, the FDA inspected K.C. Pharmaceuticals, Inc's Pomona site. Explore the inspectional observations.